BioVU

Kidney disease gene also has a protective mutation

African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt researchers have now discovered a protective genetic mutation that covers the hole to eliminate the risk.

New “DNA” podcast season explores how to harness change, ideas to improve business and medicine

Go to your favorite podcast channel right now to subscribe and listen to the first episode of Season 4!

What could be next? Preview DNA’s Season 4 exploring the future

Preview the trailer for Season 4 of the Vanderbilt Health DNA podcast series. Explore issues facing businesses across industries, and how VUMC is experimenting with and designing solutions for problems — old and new — by supporting smart people with visionary ideas. 

New reference tool supports replication of DNA biobank studies

Vanderbilt researchers created a phenotype-genotype reference map to assess data quality in DNA biobanks.

The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck

Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery.

Ann Walker, Research Assistant III, spins blood samples on a carousel prior to DNA extraction.

Alliance for Genomic Discovery FAQs

Here are frequently asked questions about Vanderbilt University Medical Center’s Alliance for Genomic Discovery.

1 2 3 4 8